Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
08/2010
08/11/2010EP1499294B1 Polymerized lipids modified with peptides used as delivery system for micronutrients
08/11/2010EP1150676B1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
08/11/2010CN101801941A Pharmaceutical containing ppar delta agonist
08/11/2010CN101801391A Use of hyaluronic acid for preparing compositions particularly for improving the function of skin, eye and mucous membrane protection
08/11/2010CN101801387A compositions comprising quinolone and methods for treating or controlling infections
08/11/2010CN101801366A Titration package for NERAMEXANE and its use in the treatment of an inner ear disorder
08/11/2010CN101801365A Interval therapy for the treatment of tinnitu
08/11/2010CN101798306A Uncaria alkaloid monomer as well as preparation method and application thereof
08/11/2010CN101797348A Traditional Chinese medicine for treating proliferative vitreoretinopathy
08/11/2010CN101797332A Traditional Chinese medicine for treating chronic dacryocystitis and preparation method thereof
08/11/2010CN101797331A Traditional Chinese medicine formula of application for preventing ophthalmic diseases
08/11/2010CN101797314A Medicinal composition for treating adolescent myopia and preparation method thereof
08/11/2010CN101797252A Application of Huperzine A in preparing medicaments
08/11/2010CN101797237A Betahistine mesilate orally disintegrating tablet and preparation method thereof
08/11/2010CN101797223A Huperzine A preparations for eyes and application thereof
08/10/2010US7772392 prostaglandin receptor agonists; for treating various ocular hypertensive conditions such as post-surgical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts
08/10/2010US7772260 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
08/10/2010US7772258 such as conjunctivitis via administering (+)-3-[3-[(1S,2S,4R)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one; phosphodiesterase inhibitors; for topical administration and for use as drops
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents
08/10/2010CA2369457C Ocular treatment using cyclosporin-a derivatives
08/05/2010WO2010087467A1 Delta-5-desaturase inhibitors
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087207A1 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
08/05/2010WO2010086828A2 Agonist anti-trkb monoclonal antibodies
08/05/2010WO2010062905A9 Lateral ventricle cell compositions and use for treating neural degenerative diseases
08/05/2010US20100197918 2,4-pyrimidinediamine compounds and their uses
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197800 Treatment and/or Prevention of Presbycusis by Modulation of Metabotropic Glutamate Receptor 7
08/05/2010US20100197788 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid
08/05/2010US20100197708 Indole compounds
08/05/2010US20100197702 Ophthalmic composition with nitric oxide donor compound and method of forming and using same
08/05/2010US20100197701 Method of treating diabetes
08/05/2010US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
08/05/2010US20100197683 Fused ring compound and use thereof
08/05/2010US20100197615 Synthesis of compounds useful as modulators of amyloid-beta production
08/05/2010US20100197580 Parstatin peptides and uses thereof
08/05/2010US20100196496 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
08/05/2010US20100196435 Materials and methods for delivering compositions to selected tissues
08/05/2010US20100196415 Process for purifying guar
08/05/2010CA2750188A1 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213737A1 Double-stranded oligonucleotides
08/04/2010EP2213308A1 Eyedrop comprising agar
08/04/2010EP2213303A1 Pharmaceutical composition for treatment of cataract
08/04/2010EP2213292A1 Double-stranded oligonucleotides
08/04/2010EP2212276A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
08/04/2010EP1920778B1 Composition for treatment of uveitis
08/04/2010EP1819362B1 Topical nepafenac formulations
08/04/2010CN101795692A Therapeutic substituted cyclopentanes for reducing intraocular pressure
08/04/2010CN101795679A 1-amino-alkylcyclohexane derivatives for the treatment of cochlear tinnitus
08/04/2010CN101791290A Tetra-acetylated puerarin self-micro emulsifying medicament delivery system and preparation method thereof
08/04/2010CN101647775B Micronomicin sulfate eye drop and preparation method thereof
08/04/2010CN101006860B Smoke-roasting bamboo salt and its making method
08/03/2010US7767672 Aminopyrimidines useful as kinase inhibitors
08/03/2010US7767429 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradename
08/03/2010US7767223 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
08/03/2010CA2461426C Imidazo-pyrimidine derivatives as ligands for gaba receptors
08/03/2010CA2444269C Treatment of disorders secondary to organic impairments
08/03/2010CA2441792C Carboline derivatives as inhibitors of phosphodiesterase 5 (pdes) for the treatment of cardiovascular diseases and erectile dysfunction
08/03/2010CA2409828C Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
08/03/2010CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors
08/03/2010CA2401342C Human antibodies against eotaxin and their use
08/03/2010CA2396524C System for stabilizing lacrimal fluid layer
08/03/2010CA2190365C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene
08/03/2010CA2188813C Angiostatin protein, nucleic acids encoding the same and methods of detection
07/2010
07/29/2010WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
07/29/2010WO2010083636A1 An eyedrops of the deproteinized calf blood extract
07/29/2010WO2010083582A1 Use of deferiprone for treatment and prevention of iron-related eye disorders
07/29/2010WO2010060934A3 Cnnm proteins and uses thereof
07/29/2010WO2010020307A3 Indazole-5-carboxylic acid hydrazide derivatives
07/29/2010US20100190841 Genetic suppression and replacement
07/29/2010US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof
07/29/2010US20100190834 Composition for ophtalmic disease associated with hypoxia or ischemia
07/29/2010US20100190833 Pharmaceutical containing ppara agonist
07/29/2010US20100190830 (3-Amino-1,2,3,4-Tetrahydro-9H-Carbazol-9-yl)-Acetic Acid Derivatives
07/29/2010US20100190829 Renin inhibitors
07/29/2010US20100190788 Amide derivatives as kinase inhitors
07/29/2010US20100190770 Compositions and methods for inhibition of the jak pathway
07/29/2010US20100190756 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS
07/29/2010US20100190754 Azolylmethylidenehydrazine derivative and use thereof
07/29/2010US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases
07/29/2010US20100190746 Quinazolinones as potassium channel modulators
07/29/2010US20100190734 Method of treating dry eye disease with azithromycin
07/29/2010US20100190717 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents
07/29/2010US20100189819 Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer
07/29/2010US20100189817 Treating Glaucoma
07/29/2010US20100189801 Drug Delivery Systems and Use Thereof
07/29/2010US20100189770 Bioerodible patch
07/29/2010US20100189766 Substance delivering punctum implants and methods
07/29/2010US20100189765 Implantable ocular drug delivery device and methods
07/29/2010US20100189686 Albumin Fusion Proteins
07/29/2010CA2750599A1 Use of deferiprone for treatment and prevention of iron-related eye disorders
07/29/2010CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
07/28/2010EP2210092A2 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
07/28/2010EP2209807A1 Anti-factor b antibodies and their uses
1 ... 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 ... 531